A detailed history of Mirabaud Asset Management LTD transactions in Dexcom Inc stock. As of the latest transaction made, Mirabaud Asset Management LTD holds 41,445 shares of DXCM stock, worth $2.84 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares
41,445
Previous 63,568 34.8%
Holding current value
$2.84 Million
Previous $8.82 Billion 46.7%
% of portfolio
2.16%
Previous 3.56%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$110.31 - $140.45 $2.44 Million - $3.11 Million
-22,123 Reduced 34.8%
41,445 $4.7 Billion
Q1 2024

Aug 12, 2024

BUY
$114.22 - $140.1 $2.12 Million - $2.6 Million
18,586 Added 41.32%
63,568 $8.82 Billion
Q4 2023

Aug 07, 2024

BUY
$75.49 - $124.16 $3.4 Million - $5.58 Million
44,982 New
44,982 $5.58 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mirabaud Asset Management LTD Portfolio

Follow Mirabaud Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabaud Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mirabaud Asset Management LTD with notifications on news.